Lv4
590 积分 2024-07-19 加入
Ramucirumab versus placebo in combination with second-line FOLFIRI in patients with metastatic colorectal carcinoma that progressed during or after first-line therapy with bevacizumab, oxaliplatin, and a fluoropyrimidine (RAISE): a randomised, double-blind
1个月前
已完结
Regorafenib-avelumab combination in patients with biliary tract cancer (REGOMUNE): a single-arm, open-label, phase II trial
2个月前
已完结
[Endoscopic management of gynecological malignancies: an update. 2007]
7个月前
已关闭
Predictive Factors for Surgical Morbidities and Adjuvant Chemotherapy Delay for Advanced Ovarian CancerPatients Treated by Primary Debulking Surgery or Interval Debulking Surgery
7个月前
已完结
European Society of Gynaecological Oncology guidelinesfor the peri-operative management of advanced ovarian cancer patients undergoing debulkingsurgery
7个月前
已完结
A laparoscopy-basedscore to predict surgical outcome in patients with advancedovarian carcinoma:a pilot study
7个月前
已完结
Nomogram for predicting incomplete cytoreduction in advanced ovarian cancer patients
7个月前
已完结
Neoadjuvant Immunotherapy in Locally Advanced Mismatch Repair-Deficient Colon Cancer
8个月前
已完结
Expert consensus on organizing the multidisciplinary team (MDT) diagnosis and treatment of hepato-pancreato-biliary diseases in China
8个月前
已完结
Distribution of per- and polyfluoroalkyl substances in blood, serum, and urine of patients with liver cancer and associations with liver function biomarkers
8个月前
已完结
皖公网安备34019202002308
